副主任医师,硕士生导师。科室及职务：肿瘤中心总支副书记、肿瘤Ⅰ科书记兼主任。诊疗专长：善于运用最先进的理论、循证医学证据和高端放疗、靶向、免疫、化疗等手段，精准诊治胸部肿瘤、消化系统肿瘤、泌尿生殖系统肿瘤；崇尚科学、规范、人性的医疗理念，与欧美多家机构合作开展多项临床研究。学术任职与荣誉：中国抗癌协会（CACA）肺癌专业委员会委员；中国抗癌协会（CACA）肿瘤放射治疗专委会肺癌学组委员；中国临床肿瘤学会（CSCO）肿瘤生物标志物专委会委员；华人放疗协作组（CRTOG）肺癌专委会委员；中国老年保健学会肺癌专业委员会常委；湖北省医学会肿瘤学分会常委；湖北省临床肿瘤学会（ESCO）第二届理事会常务理事；湖北省临床肿瘤学会（ESCO）肺癌专委会常委；湖北省临床肿瘤学会（ESCO）肺癌青年专委会主委；湖北省临床肿瘤学会（ESCO）纵隔肿瘤专委会副主委；湖北省临床肿瘤学会（ESCO）分子影像专委会常委；湖北省临床肿瘤学会（ESCO）食管癌专委会常委；湖北省肿瘤专科联盟第一届理事会副理事长；湖北省抗癌协会第八届理事会常务理事；湖北省抗癌协会肿瘤内科治疗专委会副主委；湖北省抗癌协会肿瘤营养与代谢专委会副主委；湖北省抗癌协会肺癌专委会常委兼秘书；获湖北省自然科学优秀学术论文二等奖1项；黄石市科技进步二等奖1项；武汉大学人民医院“医疗菁英”、“人民抗疫英模”等荣誉。科研成果：1、YGLi#,JChen#,BWang#,ZWXu,CWu,JFMa,QBSong,QGeng,JMYu*,HDPei*,YYao*.FOXK2affectscancercellresponsetochemotherapybypromotingnucleotidedenovosynthesis.DrugResistUpdate.2023,67:100926.2、SJHe#,SZhang#,YYao#,etal.TurbulenceofGlutamineMetabolisminPan-cancerPrognosisandImmuneMicroenvironment.FrontOncol.2022,12:1064127.3、ZYZhang#,YDong#,BWu#,YGLi,ZHLiu,ZMLiu,YJGao,LKGao,QBSong*,ZLZheng*,YYao*.Irradiationenhancesthemalignancy-promotingbehaviorsofcancer-associatedfibroblasts.FrontOncol.2022,12:9656604、YYao,JZhou,HHZhang,etal.Identificationandvalidationforbiologicalcharacteristicandprognosisoftumormicroenvironmentsubtypesinpatientswithlungadenocarcinoma.JClinOncol.2022,40(16suppl):e210065、HHZhang#,YYao#,JWu#,etal.Comprehensiveanalysisidentifiesandvalidatesthetumormicroenvironmentsubtypestopredictanti-tumortherapiesefficacyinHepatocellularcarcinoma.FrontImmunol.2022;13:8383746、YDong#,YGLi#,YYao*,etal.Anoveldefinedm7Gregulatorsignaturetoinvestigatetheassociationbetweenmolecularcharacterizationandclinicalsignificanceinlungadenocarcinoma.FrontOncol.2022,12:897323.7、ZMLiu,JWang,FBLiao,QBSong,YYao*.Tumor-educatedplateletsfacilitatethrombusformationthroughmigration.FrontOncol.2022,12:857865.8、SQYang#,YYao#,*,YDong,etal.Predictradiationpneumonitisusingagenome-scalefluxanalysisonRNA-seqderivedfromperipheralblood.FrontMed.2021,8:7159619、BXu#,KHSong#,YYao#,etal.IndividualizedmodelforpredictingCOVID-19deteriorationinpatientswithcancer:Amulticenterretrospectivestudy.CancerSci.2021,112(6):2522-2532.10、YYao#,YXChu#,BXu,etal.Riskfactorsfordistantmetastasisofpatientswithprimarytriple-negativebreastcancer.BiosciRep.2019,39(6):BSR20190288.11、SFYe#,XFChen#,YYao#,*,etal.ThioredoxinReductaseasaNovelandEfficientPlasmaBiomarkerfortheDetectionofNon-SmallCellLungCancer:aLarge-scale,Multicenterstudy.SciRep.2019,9(1):265212、YYao#,YXChu#,BXu,etal.Radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer.CancerMed.2019,8(2):554-563.13、YYao#,*,MPeng#,QLShen#,etal.DetectingEGFRMutationsandALK/ROS1RearrangementsinNon-SmallCellLungCancerUsingMalignantPleuralEffusionSamples.ThoracCancer.2019,10(2):193-20214、ZhangC#,ZengWF#,YaoYi#,etal.Naringeninamelioratesradiation-inducedlunginjurybyloweringIL-1βlevel.JPharmacolExpTher.2018,366(2):341-348.15、YaoY#,*,ZhengZL,SongQB.Mesenchymalstemcells:adouble-edgedswordinradiation-inducedlunginjury.ThoracCancer.2018,9(2):208-217.